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Solar urticaria was first described as a distinct
clinical entity by Merklen (1) in 1904. Shortly
thereafter, Ward (2) conducted the first studies
eliciting urtiearial lesions under controlled
conditions. Stevanovie (3), in a recent review of
the world literature, cited more than 70 docu-
mented cases of solar urticaria which also
included patients from the extensive reviews of
Epstein (4), Rajka (5) and Fideisberger (6). In
this paper we report 5 additional cases seen dur-
ing the past 3 years, and present a tentative
classification based on the biophysical, bio-
chemical and immunologic features of these cases
and of patients previously observed by others.
METHOD AND MATERIALS
The salient aspects of the clinical histories of
the 5 patients are summarized in Table I. The
group included 3 males and 2 females. The patients
were in good general health and none knew of any
family member having a similar condition. The
mean age of onset was 30 years and the duration of
the disease ranged from one to seven years. In
only one of the five eases was there evidence of an
atopic background.
The laboratory studies performed included;
Action Spectrum: The specific wavelengths of
electromagnetic energy eliciting the urticarial
reactions were ascertained using both natural
sunlight, and light from 2 types of fluorescent
tubes. The tubes, mounted in groups of four as
shown in Fig. 1, were Westinghouse FS2O Sun-
lamps having a continuous spectrum mainly in
the 2800A° to 3200A° range with a peak emission
at 3150 A°, and General Electric F2OT12BL Black
lights having a continuous spectrum ranging from
3200A° to 4200A° with a peak emission at 3650A°.
Reasonable similarity between exposure to artifi-
cial light sources and natural sunlight was
achieved with the use of light filters which
included window glass, Mylar type 500 (E. I.
Dupont de Nemours & Co., Wilmington, Dela-
ware), and Corning light filters (Corning Glass
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Co., Owens Illinois). The amount of energy re-
quired to elicit the reactions was determined
with an ultraviolet light meter (Hanovia Co.
Newark, N. J., Cat. #2484) and a thermopile
(Eppley Laboratory, Newport, R. I. #4259).
Passive Transfer Test: The technic was the usual
one, i.e. the intradermal injection of 0.15 ml of
serum obtained from a patient with solar urticaria
into a site on the flexor aspect of the forearm of
volunteer recipients. Irradiation of this site was
performed 6 to 48 hours later. The controls in-
cluded; (1) the patient's serum injected but not
irradiated, (2) a control serum from a "normal"
volunteer injected and irradiated under similar
conditions, and (3) a control serum from the same
"normal" volunteer injected but not irradiated.
Reverse Passive Transfer Test: The technic was
the same as that described by Epstein (4). The
forearm of the volunteer recipient was irradiated
and 30 minutes later one site each in the irradiated
area was injected with 0.15 ml of serum from the
solar urticaria patient and from a "normal"
control individual. A positive test was indicated
by formation of a wheal with the patients' serum
at least ten times the size of the wheal at the con-
trol serum site.
Heat Lability of Serum Factor: This was tested
by incubating the serum at 56°C for 1 hour and
subsequent retesting of the serum for its capacity
to passively transfer the urticarial sensitivity to
light.
Erythrocyte Proto porphyrin: Assays were done
according to the procedure of Grinstein and Win-
trobe (7).
Modified Passive Cutaneous Anaphylaxis: Tests
were performed in 8 Hartley strain albino guinea
pigs. 0.15 ml serum from a patient with solar
urticaria was injected intradermally into one site
and 0.1 ml from a control volunteer into another
site (8) on the depilated dorsal skin. Four hours
later Evans Blue dye was injected intravenously
and the injected sites were irradiated with light
from an appropriate source. Thirty minutes later
the animals were killed and the reactions at the
injected sites read by measuring the size of the
dyed areas on the inner skin surface.
RESULTS
The results of the tests have been summarised
in Table II. The studies with serum indicate
three distinct patterns and at least three bands of
excitation ("action spectra").
Patient A: The action spectrum was between
2800 and 3200A°. Successful passive transfer of
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urticarial sensitivity was accomplished 7 con-
secutive times using 4 different volunteer
recipients. Qn two occasions the passive transfer
was also positive with a serum dilution up to
1:20. The reverse passive transfer test was
strongly positive. The transfer activity of the
serum was found to be heat labile. No change in
activity was produced by irradiation of the serum
before injection. Fractionation with NH4SO4
revealed that the passive transfer factor was
present in both the globulin and albumin fractions.
The globulin fraction, however, contained
approximately twice as much of the activity as
the albumin.
The modified passive cutaneous anaphylaxis
test was negative in 8 Hartly albino strain guinea
pigs.
TABLE I
Case Histories of Five Patients with Solar Urticaria
Patient Age Sex
Duration
Disease
(years)
Associated
Disease
History
of
Atopy
A 33 Male 5 None Yes
B 35 Male 4 None No
C 22 Male 7 None No
D 15 Female 1 None No
E 47 Female 1 None No
Patient B: Urticaria occurred through a 3 mm
pane of window glass, but no reaction occurred
through a Mylar Filter Type W-500, indicating
an action spectrum between 3200 and 4000A°.
Six attempts at passive transfer and reverse
passive transfer were negative.
Patients C and D: The action spectrum was
found to be in the 4000A° to 5000A° range
through the use of window glass, Mylar Filter
Type W-500, Corning 3-69, and Corning 2-62
filters. Passive transfer was readily accomplished
and the transfer activity of the serum was found
to be heat labile. Two attempts at reverse
passive transfer were negative.
Patient B: Preliminary data indicate a diffuse
action spectrum with activity throughout the
ultraviolet and visible ranges. Four attempts at
passive transfer of sensitivity have been unsucess-
ful.
The erythrocyte protoporphyrin levels in all 5
cases (Table IT) were considered to be within
normal limits.
DISCUSSION
Although solar urticaria is a relatively rare
disease, a sufficient number of cases have been
reported during the past sixty years to permit its
characterization into certain categories. In the
FIG. 1. Mounting for the bank of 4 fluorescent tubes used in phototesting
Urticaria
Type
Action
Spectrum
Passive
Transfer
Reverse
Passive
Transfer
Mechanism
I
II
III
IV
V
VI
2850—3200A°
3200—4000A°
4000A°—5000A°
4000A°—5000A°
2800A°—5000A5
4000A°
Positive
Negative
Negative
Positive
Negative
Not reported
Positive
Negative
Negative
Negative
Negative
Not reported
Allergic
Unknown—No serum factor demonstrable
Unknown—No serum factor demonstrable
Unknown—Probably allergic
Unknown—No serum factor demonstrable
Protoporphyrin (IX) acts as a photosensi-
tizer; immunologic studies not yet re-
reported
past this has been difficult for two major reasons.
The most obvious is the lack of adequate light
sources for testing patients. The discontinuous
light sources previously used often failed to emit
the specific eliciting wavelengths of energy
constituting the action spectrum. Furthermore,
while it was suspected that there may be different
pathogenetic mechanisms for solar urtiearia it is
only since the biochemical investigations (9)
by Magnus and his group using a monochromatic
light source (10) that this has been conclusively
demonstrated. It is noteworthy, however, that
the clinical disease pattern of all reported cases
of solar urticaria has been similar.
On the basis of the reports in the literature and
the findings in the additional five eases
presently reported, we are offering the follow-
ing classification of solar urtiearia (Table III).
Type I: Patients in this category are sensitive
to 2800-3200A° and have previously been
reported by S. Epstein (4, 11), Sulzberger and
Baer (12), Peal (13) and others with findings
similar to those noted in our patient A. Positive
passive and reverse passive transfer tests, heat
lability of a factor present in the globulin and
albumin fractions of serum speak strongly for an
allergic mechanism mediated by a Pransnitz-
Kuestner antibody. Studies by Sherman (14) in
selected eases of cold urticaria have indicated a
similar pattern.
Type II: This category is exemplified by our
patient B. The mechanisms producing these
cases with an action spectrum in the 3200A°
to 4000A° range with no serum transfer factor
remains unknown.
Type III: Patients in this category have been
reported among others by Plum et at (15, 16, 17,
18, 19). They are sensitive to the 4000-5000A°
range and no serum factor has been demonstrated.
The pathogenetic mechanism remains unknown.
Type ITT: Rajka (5) in 1942 was the first to
suggest that solar urticaria with a passive
transfer factor might occur at wavelengths
above 4000A°. Kesten (20) reported a similar
case also having positive passive transfer above
4000A°. To our knowledge, our patients C and D
whose blood contained a heat labile passive
transfer factor are only the third and fourth
reported cases in this category.
Type V: Studies by Magnus (21) and
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TABLE II
Immunologic and Erythrocyte Protoporph grin Findings in Five Cases of Solar Urticaria
Patient
A
B
C
D
E
Action
Spectrum
2800—3200A°
3200A°—4000A°
4000A°—5000A°
4000A°—5000A°
2800A°—6000A°
Passive
Transfer
Positive
Negative
Positive
Positive
Negative
Reverse
Passive
Transfer
Positive
Negative
Negative
Negative
Negative
Heat
Lability
Yes
Yes
Yes
Erythroryte
Pintnpnrphyrin
(pg/iSO ml)*
12
Not Done
60
24
6
* Normal erythrocyte protoporphyrin levels in control patients ranged from 0—75 pg/lOU ml. of r.b.c.
TABLE III
Classification of Solar Urticaria
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Wiskemann (22) utilizing monochromatic light
have shown that there are patients with solar
urticaria sensitive to multiple diffuse bands of
radiation. Our patient E belongs in this category.
No serum factor has been demonstrated in these
cases.
Type VI: The most significant recent advance
in the knowledge of the pathogenesis of solar
urticaria is that of Magnus et aL, (9). Their
findings of solar urticaria associated with proto-
porphyrinemia have since been confirmed by
Langhof (23) and Redeker (24). It would appear
that a familial trait probably genetic in nature
results in the overproduction of protoporphyrin
IX. Clinical manifestations usually begin in
childhood. The urinary porphyrin excretion
levels are normal but the red blood cell and fecal
protoporphyrin levels are elevated. Urticarial
lesions occur upon exposure to radiation at
4000A°, which closely corresponds to the absorp-
tion peak of the protoporphyrin molecule. It
should be noted that the photosensitivity due to
protoporphyrinemia can express itself clinically
in lesions other than solar urticaria. For example
a girl aged 7 under our observation with the
clinical manifestations of hydroa aestivale was
found to be suffering from protoporphyrinemia
with an erythrocyte porphyrin level of 570 ug/100
ml. of r.b.c.
Solar urticaria Type I fulfills all the require-
ments of an allergic urticaria mediated by a
heat labile antibody which can be demonstrated
by passive transfer and reverse passive transfer
tests. As a matter of fact since the actual allergen
is a substance formed or released in human
skin upon exposure to the eliciting wavelengths,
solar urticaria would be among the first
recognized examples of "autoimmune" disease.
Type IV also may be based on an allergic
mechanism since a heat labile passive transfer
factor, perhaps a Prausnitz-Kuestner antibody
can be demonstrated. Some doubt remains,
however, since the reverse passive transfer
factor, at least in our 2 cases, has been negative.
The mechanism mediating types II, III, and V
remains unknown.
Type VI solar urticaria clearly involves a
metabolic anomaly, probably genetically con-
ditioned. Immunologic studies, however, thus
far have not been reported so that the possibility
of a photoallergic reaction mediated by proto-
porphyrin IX or a metabolite of this compound
cannot be excluded.
It is fully realized that the classification offered
here is simply a working classification which will
have to be altered as soon as future studies
result in new knowledge of solar urticaria.
sUMMARY
The results of biochemical, biophysical and
immunologic studies in 5 patients with solar
urticaria are presented. Although the clinical
events and morphologic alterations were similar
in these 5 cases, our findings and those in cases
previously studied by others indicate that
distinctly different mechanisms can produce
solar urticaria.
A working classification based on the presently
available knowledge of solar nrticaria is offered.
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DISCUSSION
DR. FARRINGTON DANIELS, JR. (Now York,
N. Y.): We all recognize this as an excellent
piece of work, involving a great deal of effort. I
wish more of the clinical session had had an
opportunity to hear this, because, in the clinic,
they arc always asking, "Is this phototoxicity or
is this photoallcrgy?" They apparently have little
idea of what is involved in actually proving one
versus the other. I wish, therefore, that more of
them could have heard how difficult these studios
really are.
